Key result
Adding Systemic Immune-Inflammation Index significantly improves risk reclassification for carotid plaque vulnerability.
Why the study?
Do systemic inflammatory indices accurately stratify carotid plaque vulnerability in patients with carotid atherosclerosis?
Observational (n=322)
Do systemic inflammatory indices accurately stratify carotid plaque vulnerability in patients with carotid atherosclerosis?
Answers are grounded in this paper and cite their sources.
Systemic inflammatory indices, particularly the Systemic Immune-Inflammation Index, may serve as accessible, noninvasive triage tools to stratify carotid plaque vulnerability and guide contrast-enhanced ultrasound imaging.
This retrospective study evaluated a diagnostic framework integrating systemic inflammatory indices with contrast enhanced ultrasound for stratifying carotid plaque vulnerability. We included 322 patients with a mean age of 68.4 years who underwent imaging to grade intraplaque neovascularization as an established reference. The Systemic Immune-Inflammation Index, Systemic Inflammation Response Index, and pan-immune-inflammation value were analyzed alongside diagnostic performance using receiver operating characteristic curves and reclassification metrics. Results showed that higher levels of these indices were significantly associated with increased neovascularization severity. The combined model yielded an AUC of 0.822, which was comparable to that of SII alone (AUC = 0.821; DeLong P = .789). The pan-immune-inflammation value showed a high sensitivity of 88.6% for initial screening while the Systemic Inflammation Response Index demonstrated 78.3% specificity for confirming plaque instability. Adding SII to the baseline model improved reclassification and discrimination after bootstrap correction, with a continuous NRI of 0.949 (95% CI: 0.752-1.153) and an IDI of 0.266 (95% CI: 0.213-0.311). Integrating these accessible inflammatory indices with ultrasound may provide a cost-effective and noninvasive approach to vascular risk stratification, with potential value for the personalized management of patients with carotid atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Jian et al. (2026) conducted an observational in Carotid atherosclerosis (n=322). Systemic inflammatory indices (SII, SIRI, PIV) vs. Baseline model was evaluated on Reclassification and discrimination of carotid plaque vulnerability (continuous NRI 0.949, 95% CI 0.752-1.153). Adding the Systemic Immune-Inflammation Index to a baseline model improved reclassification for carotid plaque vulnerability.
Synapse has enriched 10 related papers. Consider them for comparative context: